stockrowTwist Bioscience Corporation
TWST Healthcare Biotechnology
Twist Bioscience Corporation’s revenue for fiscal 2025 (year ended September 2025) was $376.6 million, up 20.3% from fiscal 2024.
- Revenue
- +23.2%
- EPS
- −264.7%
- Free cash flow
- −7.23%
- Total debt
- 0.00%
Quarter to June 2026, against a year earlier
Follow TWST
Alert me
Twist Bioscience Corporation (TWST) Operating margin
Twist Bioscience Corporation's operating margin over the twelve months to 30 June 2026 was −33.6%, up 2.6 percentage points from fiscal 2025 (−36.2%). Over the past ten years it has ranged from −1,924.0% (fiscal 2016) to −36.2% (fiscal 2025) — the current reading is the highest in ten years. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −36.2% | 34.38 |
| FY2024 | −70.6% | 18.04 |
| FY2023 | −88.6% | 26.73 |
| FY2022 | −115.3% | 0.08 |
| FY2021 | −115.4% | 40.06 |
| FY2020 | −155.5% | 44.68 |
| FY2019 | −200.2% | 77.35 |
| FY2018 | −277.5% | 265.66 |
| FY2017 | −543.2% | 1,380.86 |
| FY2016 | −1,924.0% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | −30.7% | 10.77 |
| Mar 2026 | −41.4% | (9.69) |
| Dec 2025 | −31.7% | (1.50) |
| Sep 2025 | −30.2% | 1.13 |
| 31 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| KRYS Krystal Biotech, Inc. compare | 48.4% |
| PTGX Protagonist Therapeutics, Inc. compare | 20.7% |
| TGTX TG Therapeutics, Inc. compare | 17.1% |
| CAI Caris Life Sciences,�Inc. compare | 13.4% |
| SYRE Spyre Therapeutics, Inc. compare | 0.00% |
| MDGL Madrigal Pharmaceuticals, Inc. compare | −10.7% |
| TWST Twist Bioscience Corporation | −33.6% |
| IBRX ImmunityBio, Inc. compare | −151.9% |
| CYTK Cytokinetics, Incorporated compare | −625.2% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on TWST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement